1. Clinical, neuropathological and radiological evidence for a rare complication of rituximab therapy
- Author
-
M. Kidd, Michael P. Lunn, Estelle Healy, Mary M. Reilly, and Rahul Phadke
- Subjects
Adult ,Male ,medicine.medical_specialty ,Echovirus ,Antineoplastic Agents ,Disease ,Deafness ,medicine.disease_cause ,medicine ,Enterovirus Infections ,Humans ,Fasciitis ,Muscle, Skeletal ,Lymphoma, Follicular ,Genetics (clinical) ,Myositis ,business.industry ,Meningoencephalitis ,Dermatomyositis ,medicine.disease ,Dermatology ,Meningitis, Viral ,Surgery ,Neurology ,Pediatrics, Perinatology and Child Health ,Rituximab ,Neurology (clinical) ,business ,Complication ,Meningitis ,medicine.drug - Abstract
We report a rare case of myofasciitis and meningitis with deafness caused by systemic enterovirus infection in the setting of hypogammaglobulinaemia induced by rituximab. Whilst effective and generally safe, anti- CD 20 antibody therapy is increasingly recognised to result in unusual infectious complications to be considered in a treated patient presenting with neurological symptoms. These cases may pose diagnostic difficulties and can have atypical presentations. We present this rare complication of rituximab therapy, with histopathological confirmation of myofasciitis. In the older literature, enterovirus associated myofasciitis may have erroneously been termed dermatomyositis and we review the literature to demonstrate this important nosological point.
- Published
- 2015